Medical News

Nintedanib Improves Outcomes with Manageable AEs in Asian Pa...
Respirology

Nintedanib reduced the rate of decline in FVC over 52 weeks; -116.8 vs -207.9 in placebo in all the Asian patients...

17 Jan 2023

Additional Risk Factors Improve Mortality Prediction for Pat...
BMC Pulm Med

The findings demonstrate that currently used CAP scoring systems could underestimate the risk of influenza A-...

17 Jan 2023

Identifying Peripheral Airway Impairment Phenotype When IOS...
Ann Allergy Asthma Immunol

Impulse oscillometry (IOS) determines peripheral airway impairment (PAI) phenotype but IOS is seldom utilized...

16 Jan 2023

Bedside LUS for The Diagnosis of Pneumonia in Children Prese...
Int J Emerg Med

Bedside LUS when used by ED clinicians had good accuracy for diagnosis of pneumonia in children in a resource-...

12 Jan 2023

Our Publications

Barijak (Barictinib) Monograph

Barictinib can be useful addition for treatment of Moderate to Severe Covid 19 patients in combination with Remdesivir. Barcitinib inhibits the...

Cipmolnu (Molnupiravir) Monograph

This monograph overviews in-vitro/clinical evidence for Molnupiravir efficacy, safety and positioning.

Molnupiravir: Fact Sheet for Healthcare Givers and Recipients

This fact sheet contains the factual details about the drug molnupiravir, its restricted use under emergency situation, dosage, side effects etc....

Molnupiravir - FAQ Booklet

This document addresses frequently asked questions related to oral antiviral drug Molnupiravir in the treatment of Covid-19.

Patient Education

Molnupiravir: Fact Sheet for Healthcare Givers and Recipients

This fact sheet contains the factual details about the drug molnupiravir, its restricted use under emergency situation, dosage, side effects etc. for...

NEBUFLO Mesh Nebulizer

NEBUFLO is an active mesh nebulizer that converts liquid medication into aerosol/mist that can easily be inhaled by patients. It is portable, easy to...

GNP - Mouthpiece versus Facemask

With the evolving science of nebulization with respect to current pandemic, using the preferred patient-device interface like mouthpiece would decrea...

GNP - Precaution during Nebulization

With the evolving science of nebulization with respect to current pandemic, adherence to nebulization is most important aspect for optimal therapy th...

Device Demo

NEBUFLO Mesh Nebulizer

NEBUFLO is an active mesh nebulizer that converts liquid medication into aerosol/mist that can easily be inhaled by patients. It is portable, easy...

Multihaler

Multihaler is a multi-dose dry powder inhaler with 60 doses, with the convenience of ease of use and portability. Click on the video to see how to...

Synchrobreathe

Synchrobreathe is a breath actuated inhaler, which helps overcome the co-ordination issues associated with the pMDI. It has an inbuilt dose counter...

Guide to Nasal & Sinus Wash

Nasowash is a non-medicated, sterile and preservative-free saline solution for nasal and sinus washing. It helps in removing dust, pollens and...

Expert's Views

How to Evaluate Patient Prognosis in Pneumonia?

This session will help to understand, how to evaluate the prognosis of CAP patients in order to avoid further consequences and if needed change the...

Diagnosis of Atypical Pneumonia

Sometime, is becomes difficult to diagnose and treat the patients with atypical pneumonia. This session will talk on different methods and...

Treatment of CAP

Due to advancement in the medical science, we have many treatment modalities to treat the patient of CAP. This session will throw a light on various...

Diagnosis of Pneumonia

The diagnosis of CAP is mainly based on clinical findings and investigations to channelize the treatment protocol. This session will discuss various...

Poll

What is one major advantage of twice daily dosage for your COPD patients?

Relief of night time symptoms
42% (5 votes)
Reduced usage of rescue medications
8% (1 vote)
Significant improvement in QOL
42% (5 votes)
No real advantage over Once daily
8% (1 vote)
Total votes: 12